With the grant funding, Dr. Licciardone will look more closely at OMT use for the treatment of chronic low back pain and other musculoskeletal disorders, refinement of placebo control treatments for pain and functioning, assessment of somatovisceral and viscerosomatic manifestations of disease, and description of the natural history and epidemiology of somatic dysfunction.